New Insights into Augmentative Therapy for Parkinson’s Disease

Dear Colleagues,

Parkinson’s Disease (PD) is the second most prevalent neurodegenerative disorder in the world. It is projected that 12 to 17 million people worldwide will be affected by PD by the year 2040. In the early stages of the disease, motor symptoms can usually be treated with dopaminergic medications. However, as the disease progresses, management of drug dosage and scheduling becomes complex and often associated with motor fluctuations and dyskinesia. The symptoms of postural instability and gait disturbances (PIGDs) are particularly challenging to treat. There is a growing need for innovative therapies that can enhance the conventional treatment approaches to PD.

This Special Issue is dedicated to exploring augmentative therapies for PD. Our goal is to bring to light new developments in non-pharmacological interventions targeting motor symptoms, such as physical activity-based therapies, neuromodulation, gene therapy, etc.

In this Special Issue, we invite original articles and reviews from experts in the field. We eagerly await your contributions.

Dr. Adam Thrasher
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Parkinson’s Disease
• postural instability
• locomotion
• physical therapy
• neuromodulation
• augmentative therapies